These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37302533)

  • 1. HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer.
    Lewis BR; Garland EL; Byrne K; Durns T; Hendrick J; Beck A; Thielking P
    J Pain Symptom Manage; 2023 Sep; 66(3):258-269. PubMed ID: 37302533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder.
    Agrawal M; Richards W; Beaussant Y; Shnayder S; Ameli R; Roddy K; Stevens N; Richards B; Schor N; Honstein H; Jenkins B; Bates M; Thambi P
    Cancer; 2024 Apr; 130(7):1137-1146. PubMed ID: 38105655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.
    Davis AK; Barrett FS; May DG; Cosimano MP; Sepeda ND; Johnson MW; Finan PH; Griffiths RR
    JAMA Psychiatry; 2021 May; 78(5):481-489. PubMed ID: 33146667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial.
    Aaronson ST; van der Vaart A; Miller T; LaPratt J; Swartz K; Shoultz A; Lauterbach M; Sackeim HA; Suppes T
    JAMA Psychiatry; 2024 Jun; 81(6):555-562. PubMed ID: 38055270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.
    Rosenblat JD; Meshkat S; Doyle Z; Kaczmarek E; Brudner RM; Kratiuk K; Mansur RB; Schulz-Quach C; Sethi R; Abate A; Ali S; Bawks J; Blainey MG; Brietzke E; Cronin V; Danilewitz J; Dhawan S; Di Fonzo A; Di Fonzo M; Drzadzewski P; Dunlop W; Fiszter H; Gomes FA; Grewal S; Leon-Carlyle M; McCallum M; Mofidi N; Offman H; Riva-Cambrin J; Schmidt J; Smolkin M; Quinn JM; Zumrova A; Marlborough M; McIntyre RS
    Med; 2024 Mar; 5(3):190-200.e5. PubMed ID: 38359838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.
    Carhart-Harris RL; Bolstridge M; Day CMJ; Rucker J; Watts R; Erritzoe DE; Kaelen M; Giribaldi B; Bloomfield M; Pilling S; Rickard JA; Forbes B; Feilding A; Taylor D; Curran HV; Nutt DJ
    Psychopharmacology (Berl); 2018 Feb; 235(2):399-408. PubMed ID: 29119217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis.
    Beaussant Y; Tarbi E; Nigam K; Miner S; Sager Z; Sanders JJ; Ljuslin M; Guérin B; Thambi P; Tulsky JA; Agrawal M
    Cancer; 2024 Apr; 130(7):1147-1157. PubMed ID: 38105653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer.
    Agin-Liebes GI; Malone T; Yalch MM; Mennenga SE; Ponté KL; Guss J; Bossis AP; Grigsby J; Fischer S; Ross S
    J Psychopharmacol; 2020 Feb; 34(2):155-166. PubMed ID: 31916890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.
    Gukasyan N; Davis AK; Barrett FS; Cosimano MP; Sepeda ND; Johnson MW; Griffiths RR
    J Psychopharmacol; 2022 Feb; 36(2):151-158. PubMed ID: 35166158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.
    Bogenschutz MP; Ross S; Bhatt S; Baron T; Forcehimes AA; Laska E; Mennenga SE; O'Donnell K; Owens LT; Podrebarac S; Rotrosen J; Tonigan JS; Worth L
    JAMA Psychiatry; 2022 Oct; 79(10):953-962. PubMed ID: 36001306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psilocybin-assisted therapy improves psycho-social-spiritual well-being in cancer patients.
    Shnayder S; Ameli R; Sinaii N; Berger A; Agrawal M
    J Affect Disord; 2023 Feb; 323():592-597. PubMed ID: 36513161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.
    Haikazian S; Chen-Li DCJ; Johnson DE; Fancy F; Levinta A; Husain MI; Mansur RB; McIntyre RS; Rosenblat JD
    Psychiatry Res; 2023 Nov; 329():115531. PubMed ID: 37844352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.
    Carhart-Harris RL; Bolstridge M; Rucker J; Day CM; Erritzoe D; Kaelen M; Bloomfield M; Rickard JA; Forbes B; Feilding A; Taylor D; Pilling S; Curran VH; Nutt DJ
    Lancet Psychiatry; 2016 Jul; 3(7):619-27. PubMed ID: 27210031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD.
    Davis AK; Levin AW; Nagib PB; Armstrong SB; Lancelotta RL
    BMJ Open; 2023 May; 13(5):e068884. PubMed ID: 37142308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial.
    Sloshower J; Skosnik PD; Safi-Aghdam H; Pathania S; Syed S; Pittman B; D'Souza DC
    J Psychopharmacol; 2023 Jul; 37(7):698-706. PubMed ID: 36938991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trial of Psilocybin versus Escitalopram for Depression.
    Carhart-Harris R; Giribaldi B; Watts R; Baker-Jones M; Murphy-Beiner A; Murphy R; Martell J; Blemings A; Erritzoe D; Nutt DJ
    N Engl J Med; 2021 Apr; 384(15):1402-1411. PubMed ID: 33852780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study.
    Anderson BT; Danforth A; Daroff PR; Stauffer C; Ekman E; Agin-Liebes G; Trope A; Boden MT; Dilley PJ; Mitchell J; Woolley J
    EClinicalMedicine; 2020 Oct; 27():100538. PubMed ID: 33150319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorder.
    Heinzerling KG; Sergi K; Linton M; Rich R; Youssef B; Bentancourt I; Bramen J; Siddarth P; Schwartzberg L; Kelly DF
    Front Psychiatry; 2023; 14():1215972. PubMed ID: 37795513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.
    Grob CS; Danforth AL; Chopra GS; Hagerty M; McKay CR; Halberstadt AL; Greer GR
    Arch Gen Psychiatry; 2011 Jan; 68(1):71-8. PubMed ID: 20819978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.
    Pearson C; Siegel J; Gold JA
    J Neurol Sci; 2022 Mar; 434():120096. PubMed ID: 34942586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.